Related Experiment Video
Updated: Feb 14, 2026

A Novel Model of Mild Traumatic Brain Injury for Juvenile Rats
Published on: December 8, 2014
Blood biomarkers in paediatric mild traumatic brain injury: a systematic review
Micaela Lugones1, Georgia Parkin1, Stefan Bjelosevic1
1Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Insights
Blood biomarkers show promise for diagnosing and monitoring paediatric mild traumatic brain injury (mTBI). GFAP and UCH-L1 are key candidates, but more uniform research is needed for definitive conclusions.
Area of Science:
- Neurology
- Biochemistry
- Pediatrics
Background:
- Mild traumatic brain injury (mTBI) in children presents diagnostic challenges.
- Current diagnostic methods for paediatric mTBI can be invasive or lack specificity.
- There is a need for objective blood-based markers in paediatric mTBI.
Purpose of the Study:
- To review current research on blood biomarkers for paediatric mTBI.
- To assess the diagnostic, prognostic, and monitoring potential of these biomarkers.
- To identify promising biomarkers for future clinical application.
Main Methods:
- Systematic review adhering to PRISMA guidelines.
- Searched MEDLINE, PubMed, and EMBASE databases.
- Included 21 studies evaluating 14 different biomarkers.
Main Results:
- 81% of studies found significant associations between biomarkers and mTBI.
- Results are diverse and sometimes conflicting across studies.
- GFAP shows promise for prognosis/monitoring; UCH-L1 for diagnosis.
Conclusions:
- Blood biomarkers hold potential for paediatric mTBI management.
- Heterogeneity in studies hinders definitive conclusions.
- Standardized research is crucial for validating biomarkers in paediatric mTBI.
Objective:
To summarize all current studies focusing on blood biomarkers in paediatric mild traumatic brain injury (mTBI) and to outline the possible use of blood biomarkers for diagnostic, prognostic and monitoring purposes within this setting.
Methods:
A systematic review following the PRISMA guidelines was conducted using the MEDLINE, PubMed and EMBASE databases.
Results:
A total of 21 studies were included in the review, encompassing a total of 14 different biomarkers. Seventeen (81%) of these studies found a significant association between biomarker concentration and mTBI characteristics, however results from studies to date are diverse and at times conflicting.
Conclusion:
GFAP appears to be a promising blood biomarker for the prognosis and monitoring of mTBI, whereas UCH-L1 appears more promising at mTBI diagnosis. Despite this, the overall heterogeneity in assessed biomarkers, study design and measurement tools has made drawing specific conclusions challenging. Future research will require more uniform study design and methodological approaches to allow for the comparison, corroboration and validation of blood biomarkers within the context of paediatric mTBI.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
The Blood-brain Barrier
Random and Systematic Errors
Systematic Sampling Method
Systematic sampling is one of the simplest methods...

